Zoledronic Acid Injection, Solution, Concentrate
Product Images NDC 0143-9642
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 0143-9642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Cockcroft-gault Formula (Zoledronic Acid Injection 2)
Figure 1 Proportion Of Complete Responders By Day 10 In Pooled Hcm Studies (Zoledronic Acid Injection 3)
Ndc 0143-9642-01 Zoledronic Acid Injection 4 mg/5 mL (0.8 mg/ml) Sterile Concentrate Concentrate For Intravenous Infusion Rx Only 5 mL Single Dose Vial Not For Direct Injection. Dose Must Be Diluted. Do Not Mix With Calcium-containing Infusion Solutions. Usual Dosage: See Package Insert. Discard Unused Portion. Store At 25º (77ºf); Excursions Permitted To 15º To 30ºc (59º To 86ºf) [see Usp Controlled Room Temperature]. (Zoledronic Acid Injection 4)
Zoledronic Acid is a sterile concentrate meant for intravenous infusion. The dosage must be diluted and its usage instructions are mentioned in the package insert. It must not be mixed with calcium-containing infusion solutions. The unused portion must be discarded. The concentrate is available in a single-dose vial manufactured by Hika Farmageutica (Portugal) SA. The storage temperature range is between 15°C to 30°C (59°F to 86°F).*
Zoledronic Acid Injection 5
Zoledronic Acid Injection 6
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.